東北大学大学院医学系研究科
血液内科学分野
Department of Hematology, Tohoku University Graduate School of Medicine.
東北大学病院 血液内科
Department of Hematology, Tohoku University Hospital,.

サイトマップ

教室案内

業績

主要論文 2018年

  1. Kato H, Itoh-Nakadai A, Matsumoto M, Ishii Y, Watanabe-Matsui M, Ikeda M, Ebina-Shibuya R, Sato Y, Kobayashi M, Nishizawa H, Suzuki K, Muto A, Fujiwara T, Nannya Y, Malcovati L, Cazzola M, Ogawa S, Harigae H, Igarashi K. Infection perturbs Bach2- and Bach1-dependent erythroid lineage 'choice' to cause anemia. Nat Immunol. 2018 Oct;19(10):1059-1070. doi: 10.1038/s41590-018-0202-3.
  2. Hatta S, Fujiwara T, Yamamoto T, Saito K, Kamata M, Tamai Y, Kawamata S, Harigae H. A defined culture method enabling the establishment of ring sideroblasts from induced pluripotent cells of X-linked sideroblastic anemia. Haematologica. 2018 May;103(5):e188-e191. doi: 10.3324/haematol.2017.179770.
  3. Ichikawa S, Fukuhara N, Onishi Y, Ichinohasama R, Harigae H. Sustained Remission of γδ T-Cell Lymphoma by Graft-Versus-Lymphoma Effect That Relapsed Early After Cord Blood Transplantation. Clin Lymphoma Myeloma Leuk. 2018 Sep;18(9):e369-e372. doi: 10.1016/j.clml.2018.06.019.
  4. Ichikawa S, Fukuhara N, Hatta S, Himuro M, Katsushima H, Nasu K, Ono K, Inokura K, Kobayashi M, Onishi Y, Fujii H, Ishizawa K, Ichinohasama R, Harigae H. Successful Cord Blood Stem Cell Transplantation for Primary Cutaneous CD8-positive Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Complicated with Cerebral Infiltration. Intern Med. 2018 Jul 15;57(14):2051-2055. doi:10.2169/internalmedicine.0568-17.
  5. Ichikawa S, Fukuhara N, Hatta S, Himuro M, Nasu K, Ono K, Okitsu Y, Kobayashi M, Onishi Y, Ri M, Ichinohasama R, Harigae H. Anaplastic multiple myeloma: possible limitations of conventional chemotherapy for long-term remission. J Clin Exp Hematop. 2018;58(1):39-42. doi: 10.3960/jslrt.17035.
  6. Ono K, Onishi Y, Kobayashi M, Hatta S, Nasu K, Watanabe S, Ichikawa S, Okitsu Y, Fukuhara N, Harigae H. γδ T cell clonal proliferation early after PD-1 blockade. Ann Hematol. 2019 Jan;98(1):219-220. doi: 10.1007/s00277-018-3406-6.
  7. Ono K, Onishi Y, Kobayashi M, Ichikawa S, Hatta S, Watanabe S, Okitsu Y, Fukuhara N, Ichinohasama R, Harigae H. Successful Treatment of Aggressive Mature B-cell Lymphoma Mimicking Immune Thrombocytopenic Purpura. Intern Med. 2018 Sep1;57(17):2573-2579. doi: 10.2169/internalmedicine.0560-17.
  8. Ishii Y, Shirai T, Hoshi Y, Fujita Y, Shirota Y, Fujii H, Ishii T, Harigae H. Nasal Septal Perforation in Propylthiouracil-Induced Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Case Rep Rheumatol. 2018 Mar 22;2018:8192021. doi: 10.1155/2018/8192021.
  9. Machiyama T, So T, Okuyama Y, Kobayashi S, Phung HT, Asao A, Harigae H, Ishii N. TNF receptor associated factor 5 controls oncostatin M-mediated lung inflammation. Biochem Biophys Res Commun. 2018 May 15;499(3):544-550. doi:10.1016/j.bbrc.2018.03.186.
  10. Shirai T, Hanaoka R, Goto Y, Kojima I, Ishii Y, Hoshi Y, Fujita Y, Shirota Y, Fujii H, Ishii T, Harigae H. Takayasu Arteritis Coexisting with Sclerosing Osteomyelitis. Intern Med. 2018 Jul 1;57(13):1929-1934. doi:10.2169/internalmedicine.0329-17.
  11. Ishii T, Tanaka Y, Kawakami A, Saito K, Ichinose K, Fujii H, Shirota Y, Shirai T, Fujita Y, Watanabe R, Chiu SW, Yamaguchi T, Harigae H. Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosus. Mod Rheumatol. 2018 Nov;28(6):986-992. doi: 10.1080/14397595.2018.1432331.
  12. Ohashi K, Fujiwara T, Onodera K, Saito Y, Ichikawa S, Kobayashi M, Okitsu Y, Fukuhara N, Onishi Y, Harigae H. Establishment of a Screening System to Identify Novel GATA-2 Transcriptional Regulators. Tohoku J Exp Med. 2018 Jan;244(1):41-52. doi: 10.1620/tjem.244.41.
  13. Harigae H. Iron metabolism and related diseases: an overview. Int J Hematol. 2018 Jan;107(1):5-6. doi: 10.1007/s12185-017-2384-0.
  14. Shimada S, Nakamichi T, Yamada G, Narumi K, Usubuchi H, Yamamoto T, Ichikawa S, Fukuhara N, Miyazaki M, Harigae H, Sato H, Ito S. Concurrent isolated IgG2-positive membranous nephropathy and malignant B-cell lymphoma. CEN Case Rep. 2018 Nov;7(2):248-252. doi: 10.1007/s13730-018-0336-z.
  15. Ishida H, Imamura T, Morimoto A, Fujiwara T, Harigae H. Five-aminolevulinic acid: New approach for congenital sideroblastic anemia. Pediatr Int. 2018 May;60(5):496-497. doi: 10.1111/ped.13558.
  16. Mishima E, Suzuki T, Takeuchi Y, Seiji K, Fukuhara N, Takase K, Harigae H, Abe T, Ito S. Renovascular hypertension associated with JAK2 V617F positive myeloproliferative neoplasms treated with angioplasty: 2 cases and literature review. J Clin Hypertens (Greenwich). 2018 Apr;20(4):798-804. doi:10.1111/jch.13257.
  17. Watanabe T, Tobinai K, Wakabayashi M, Morishima Y, Kobayashi H, Kinoshita T, Suzuki T, Yamaguchi M, Ando K, Ogura M, Taniwaki M, Uike N, Yoshino T, Nawano S, Terauchi T, Hotta T, Nagai H, Tsukasaki K; JCOG0203 Collaborators. Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial. Lancet Haematol. 2018 Nov;5(11):e520-e531. doi: 10.1016/S2352-3026(18)30155-8.
  18. Kawakami T, Nakazawa H, Kawakami F, Matsuzawa S, Sudo Y, Sakai H, Nishina S, Senoo N, Senoo Y, Komatsu M, Umemura T, Yamaguchi T, Kosho T, Fujiwara T, Harigae H, Ishida F. [Successful treatment of X-linked sideroblastic anemia with ALAS2 R452H mutation using vitamin B(6)]. Rinsho Ketsueki. 2018;59(4):401-406. doi:10.11406/rinketsu.59.401.
  19. Kameoka Y, Akagi T, Murai K, Noji H, Kato Y, Sasaki O, Ito S, Ishizawa K, Ishida Y, Ichinohasama R, Harigae H, Takahashi N. Safety and efficacy of high-dose ranimustine (MCNU) containing regimen followed by autologous stem cell transplantation for diffuse large B-cell lymphoma. Int J Hematol. 2018 Nov;108(5):510-515. doi: 10.1007/s12185-018-2508-1.
  20. Noguchi S, Nakaseko C, Nishiwaki K, Ogasawara H, Ohishi K, Tokuhira M, Noguchi M, Kimura H, Handa H, Mitani K, Miura M, Wakita H, Takahashi N; STAT study group. Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan. Int J Hematol. 2018 Aug;108(2):176-183. doi:10.1007/s12185-018-2459-6.
  21. Murakami S, Suzuki T, Yokoyama W, Yagi S, Matsumura K, Nakajima Y, Harigae H, Fukamizu A, Motohashi H. Nucleomethylin deficiency impairs embryonic erythropoiesis. J Biochem. 2018 May 1;163(5):413-423. doi: 10.1093/jb/mvx086.PubMed PMID: 29244083.